Overview of endoscopic procedures performed and serious pathology detected in COVID-19 era versus pre-COVID-19 era
| COVID-19 era | Pre-COVID-19 era | P value | |
| Procedure, n (%) | |||
| Gastroscopy | 54 (38.3) | 220 (53.7) | |
| Colonoscopy | 87 (61.7) | 190 (46.3) | 0.002 |
| Procedure timing, n (%) | |||
| Emergency | 16 (11.3) | 18 (4.4) | |
| Elective | 125 (88.7) | 392 (95.6) | 0.004 |
| Highly significant pathology, n (%) | |||
| Upper GI malignancy | 4 (7.4) | 4 (1.8) | 0.128 |
| Lower GI malignancy | 2 (2.3) | 3 (1.6) | 0.466 |
| Adenoma >2 cm | 3 (3.4) | 5 (2.6) | 0.443 |
| HGD polyp | 3 (3.4) | 5 (2.6) | 0.443 |
| New diagnosis IBD | 5 (5.7) | 1 (0.5) | 0.014 |
GI, gastrointestinal; HGD, high-grade dysplasia; IBD, inflammatory bowel disease.